LEADERSHIP
Scientific leadership grounded in decades of therapeutic innovation.
INVENT Pharmaceuticals is led by experienced leadership with deep expertise in management, science, technology and as a visionary drug hunter with decades of experience in drug discovery and development from world class biotech and pharmaceutical companies.
Dale Dhanoa, Ph.D.
Chief Executive Officer
Dr. Dale Dhanoa is the CEO of INVENT Pharmaceuticals and brings more than 25 years of leadership experience across pharmaceutical research, drug discovery, company operations, and strategic partnering.
Over the course of his career, Dr. Dhanoa has led discovery and development of innovative therapeutics, business and corporate development. His experience includes senior and executive leadership and management positions at Predix Pharmaceuticals, Synaptic Pharmaceuticals, Alanex Corporation (acquired by Agouron and later became part of Pfizer) and 3- Dimensional Pharmaceuticals (acquired by J&J), Akaal Pharma and PharmaCore.
Dr. Dhanoa began his career at Merck Research Laboratories of Merck & Co., in Rahway, NJ, and has contributed to multiple successful biotech financings, IPOs, strategic partnerships, and M&A transactions throughout. He has established collaborations with leading pharmaceutical organizations around the world, including Novartis, Roche, Novo Nordisk, Merck KGaA, Bristol Myers Squibb, Johnson & Johnson, AstraZeneca, Amgen, and Boehringer Ingelheim.
Previous Strategic Partnerships and Collaborations
